Viral characterization of the reassortants between canine influenza H3N2 and human pandemic (2009) H1N1 and avian H9N2 viruses in canine ex vivo tracheal explants

In 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread internationally and continues to circulate in the canines. While there is currently no report of H3N2-CIV spilling over to the human population, the virus had shown a...

Full description

Saved in:
Bibliographic Details
Published inVirology journal Vol. 22; no. 1; pp. 218 - 10
Main Authors Kam, Tonia T., Bui, Christine H. T., Yeung, Hin-Wo, Wong, Peter C. H., Chin, Alex W. H., Nicholls, John M., Peiris, Malik, Hui, Kenrie P. Y., Poon, Leo L. M., Chan, Michael C. W.
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 01.07.2025
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread internationally and continues to circulate in the canines. While there is currently no report of H3N2-CIV spilling over to the human population, the virus had shown a tendency to reassort with other influenza subtypes. Given that the canine respiratory tract is susceptible to a wide range of influenza viruses, it is of interest whether H3N2-CIV are likely to reassort with human and avian IAVs to generate reassortants with increased zoonotic potential. We conducted a co-infection study in canine tracheal explants. Ex vivo canine tracheal tissues were co-infected by H3N2-CIV and two respective human and avian influenza viruses, 2009 pandemic H1N1 and avian H9N2 virus. The viruses were serially passaged in canine tracheal explants. Next-generation sequencing was conducted to investigate the reassortment pattern. The resulting reassortants were plaque-purified and inoculated in human alveolar epithelial cells to determine their replication competence and proinflammatory cytokine induction profile. Co-passaging H3N2-CIV with human/avian influenza A viruses in canine tracheal explants resulted in a high rate of reassortment. Plaque-purified reassortants were all viable and able to propagate in mammalian alveolar epithelial cells. Reassortment most frequently occurred in the MP, NA and NS segments. Selected reassortants had enhanced replication efficiency and able to induce more proinflammatory cytokines than the parental strains, suggesting that these reassortants have a considerable zoonotic risk. Our results demonstrate that ex vivo canine tracheal explants can serve as an effective platform for studying influenza virus reassortment and evolution. The ability of H3N2-CIV reassortants to replicate and induce a proinflammatory cytokine response in human alveolar epithelial cells substantiates the zoonotic potential of canine-origin influenza A viruses and suggests a risk of enhanced transmission acquired through reassortment events. These findings highlight the need for ongoing surveillance and constant vigilance regarding influenza viruses circulating in the canine population.
AbstractList In 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread internationally and continues to circulate in the canines. While there is currently no report of H3N2-CIV spilling over to the human population, the virus had shown a tendency to reassort with other influenza subtypes. Given that the canine respiratory tract is susceptible to a wide range of influenza viruses, it is of interest whether H3N2-CIV are likely to reassort with human and avian IAVs to generate reassortants with increased zoonotic potential.BACKGROUNDIn 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread internationally and continues to circulate in the canines. While there is currently no report of H3N2-CIV spilling over to the human population, the virus had shown a tendency to reassort with other influenza subtypes. Given that the canine respiratory tract is susceptible to a wide range of influenza viruses, it is of interest whether H3N2-CIV are likely to reassort with human and avian IAVs to generate reassortants with increased zoonotic potential.We conducted a co-infection study in canine tracheal explants. Ex vivo canine tracheal tissues were co-infected by H3N2-CIV and two respective human and avian influenza viruses, 2009 pandemic H1N1 and avian H9N2 virus. The viruses were serially passaged in canine tracheal explants. Next-generation sequencing was conducted to investigate the reassortment pattern. The resulting reassortants were plaque-purified and inoculated in human alveolar epithelial cells to determine their replication competence and proinflammatory cytokine induction profile.METHODSWe conducted a co-infection study in canine tracheal explants. Ex vivo canine tracheal tissues were co-infected by H3N2-CIV and two respective human and avian influenza viruses, 2009 pandemic H1N1 and avian H9N2 virus. The viruses were serially passaged in canine tracheal explants. Next-generation sequencing was conducted to investigate the reassortment pattern. The resulting reassortants were plaque-purified and inoculated in human alveolar epithelial cells to determine their replication competence and proinflammatory cytokine induction profile.Co-passaging H3N2-CIV with human/avian influenza A viruses in canine tracheal explants resulted in a high rate of reassortment. Plaque-purified reassortants were all viable and able to propagate in mammalian alveolar epithelial cells. Reassortment most frequently occurred in the MP, NA and NS segments. Selected reassortants had enhanced replication efficiency and able to induce more proinflammatory cytokines than the parental strains, suggesting that these reassortants have a considerable zoonotic risk.RESULTSCo-passaging H3N2-CIV with human/avian influenza A viruses in canine tracheal explants resulted in a high rate of reassortment. Plaque-purified reassortants were all viable and able to propagate in mammalian alveolar epithelial cells. Reassortment most frequently occurred in the MP, NA and NS segments. Selected reassortants had enhanced replication efficiency and able to induce more proinflammatory cytokines than the parental strains, suggesting that these reassortants have a considerable zoonotic risk.Our results demonstrate that ex vivo canine tracheal explants can serve as an effective platform for studying influenza virus reassortment and evolution. The ability of H3N2-CIV reassortants to replicate and induce a proinflammatory cytokine response in human alveolar epithelial cells substantiates the zoonotic potential of canine-origin influenza A viruses and suggests a risk of enhanced transmission acquired through reassortment events. These findings highlight the need for ongoing surveillance and constant vigilance regarding influenza viruses circulating in the canine population.CONCLUSIONSOur results demonstrate that ex vivo canine tracheal explants can serve as an effective platform for studying influenza virus reassortment and evolution. The ability of H3N2-CIV reassortants to replicate and induce a proinflammatory cytokine response in human alveolar epithelial cells substantiates the zoonotic potential of canine-origin influenza A viruses and suggests a risk of enhanced transmission acquired through reassortment events. These findings highlight the need for ongoing surveillance and constant vigilance regarding influenza viruses circulating in the canine population.
Abstract Background In 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread internationally and continues to circulate in the canines. While there is currently no report of H3N2-CIV spilling over to the human population, the virus had shown a tendency to reassort with other influenza subtypes. Given that the canine respiratory tract is susceptible to a wide range of influenza viruses, it is of interest whether H3N2-CIV are likely to reassort with human and avian IAVs to generate reassortants with increased zoonotic potential. Methods We conducted a co-infection study in canine tracheal explants. Ex vivo canine tracheal tissues were co-infected by H3N2-CIV and two respective human and avian influenza viruses, 2009 pandemic H1N1 and avian H9N2 virus. The viruses were serially passaged in canine tracheal explants. Next-generation sequencing was conducted to investigate the reassortment pattern. The resulting reassortants were plaque-purified and inoculated in human alveolar epithelial cells to determine their replication competence and proinflammatory cytokine induction profile. Results Co-passaging H3N2-CIV with human/avian influenza A viruses in canine tracheal explants resulted in a high rate of reassortment. Plaque-purified reassortants were all viable and able to propagate in mammalian alveolar epithelial cells. Reassortment most frequently occurred in the MP, NA and NS segments. Selected reassortants had enhanced replication efficiency and able to induce more proinflammatory cytokines than the parental strains, suggesting that these reassortants have a considerable zoonotic risk. Conclusions Our results demonstrate that ex vivo canine tracheal explants can serve as an effective platform for studying influenza virus reassortment and evolution. The ability of H3N2-CIV reassortants to replicate and induce a proinflammatory cytokine response in human alveolar epithelial cells substantiates the zoonotic potential of canine-origin influenza A viruses and suggests a risk of enhanced transmission acquired through reassortment events. These findings highlight the need for ongoing surveillance and constant vigilance regarding influenza viruses circulating in the canine population.
In 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread internationally and continues to circulate in the canines. While there is currently no report of H3N2-CIV spilling over to the human population, the virus had shown a tendency to reassort with other influenza subtypes. Given that the canine respiratory tract is susceptible to a wide range of influenza viruses, it is of interest whether H3N2-CIV are likely to reassort with human and avian IAVs to generate reassortants with increased zoonotic potential. We conducted a co-infection study in canine tracheal explants. Ex vivo canine tracheal tissues were co-infected by H3N2-CIV and two respective human and avian influenza viruses, 2009 pandemic H1N1 and avian H9N2 virus. The viruses were serially passaged in canine tracheal explants. Next-generation sequencing was conducted to investigate the reassortment pattern. The resulting reassortants were plaque-purified and inoculated in human alveolar epithelial cells to determine their replication competence and proinflammatory cytokine induction profile. Co-passaging H3N2-CIV with human/avian influenza A viruses in canine tracheal explants resulted in a high rate of reassortment. Plaque-purified reassortants were all viable and able to propagate in mammalian alveolar epithelial cells. Reassortment most frequently occurred in the MP, NA and NS segments. Selected reassortants had enhanced replication efficiency and able to induce more proinflammatory cytokines than the parental strains, suggesting that these reassortants have a considerable zoonotic risk. Our results demonstrate that ex vivo canine tracheal explants can serve as an effective platform for studying influenza virus reassortment and evolution. The ability of H3N2-CIV reassortants to replicate and induce a proinflammatory cytokine response in human alveolar epithelial cells substantiates the zoonotic potential of canine-origin influenza A viruses and suggests a risk of enhanced transmission acquired through reassortment events. These findings highlight the need for ongoing surveillance and constant vigilance regarding influenza viruses circulating in the canine population.
Background In 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread internationally and continues to circulate in the canines. While there is currently no report of H3N2-CIV spilling over to the human population, the virus had shown a tendency to reassort with other influenza subtypes. Given that the canine respiratory tract is susceptible to a wide range of influenza viruses, it is of interest whether H3N2-CIV are likely to reassort with human and avian IAVs to generate reassortants with increased zoonotic potential. Methods We conducted a co-infection study in canine tracheal explants. Ex vivo canine tracheal tissues were co-infected by H3N2-CIV and two respective human and avian influenza viruses, 2009 pandemic H1N1 and avian H9N2 virus. The viruses were serially passaged in canine tracheal explants. Next-generation sequencing was conducted to investigate the reassortment pattern. The resulting reassortants were plaque-purified and inoculated in human alveolar epithelial cells to determine their replication competence and proinflammatory cytokine induction profile. Results Co-passaging H3N2-CIV with human/avian influenza A viruses in canine tracheal explants resulted in a high rate of reassortment. Plaque-purified reassortants were all viable and able to propagate in mammalian alveolar epithelial cells. Reassortment most frequently occurred in the MP, NA and NS segments. Selected reassortants had enhanced replication efficiency and able to induce more proinflammatory cytokines than the parental strains, suggesting that these reassortants have a considerable zoonotic risk. Conclusions Our results demonstrate that ex vivo canine tracheal explants can serve as an effective platform for studying influenza virus reassortment and evolution. The ability of H3N2-CIV reassortants to replicate and induce a proinflammatory cytokine response in human alveolar epithelial cells substantiates the zoonotic potential of canine-origin influenza A viruses and suggests a risk of enhanced transmission acquired through reassortment events. These findings highlight the need for ongoing surveillance and constant vigilance regarding influenza viruses circulating in the canine population. Keywords: Influenza, Canine H3N2, Pandemic H1N1, H9N2, Reassortment, Ex vivo, Explants
In 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread internationally and continues to circulate in the canines. While there is currently no report of H3N2-CIV spilling over to the human population, the virus had shown a tendency to reassort with other influenza subtypes. Given that the canine respiratory tract is susceptible to a wide range of influenza viruses, it is of interest whether H3N2-CIV are likely to reassort with human and avian IAVs to generate reassortants with increased zoonotic potential. We conducted a co-infection study in canine tracheal explants. Ex vivo canine tracheal tissues were co-infected by H3N2-CIV and two respective human and avian influenza viruses, 2009 pandemic H1N1 and avian H9N2 virus. The viruses were serially passaged in canine tracheal explants. Next-generation sequencing was conducted to investigate the reassortment pattern. The resulting reassortants were plaque-purified and inoculated in human alveolar epithelial cells to determine their replication competence and proinflammatory cytokine induction profile. Co-passaging H3N2-CIV with human/avian influenza A viruses in canine tracheal explants resulted in a high rate of reassortment. Plaque-purified reassortants were all viable and able to propagate in mammalian alveolar epithelial cells. Reassortment most frequently occurred in the MP, NA and NS segments. Selected reassortants had enhanced replication efficiency and able to induce more proinflammatory cytokines than the parental strains, suggesting that these reassortants have a considerable zoonotic risk. Our results demonstrate that ex vivo canine tracheal explants can serve as an effective platform for studying influenza virus reassortment and evolution. The ability of H3N2-CIV reassortants to replicate and induce a proinflammatory cytokine response in human alveolar epithelial cells substantiates the zoonotic potential of canine-origin influenza A viruses and suggests a risk of enhanced transmission acquired through reassortment events. These findings highlight the need for ongoing surveillance and constant vigilance regarding influenza viruses circulating in the canine population.
ArticleNumber 218
Audience Academic
Author Peiris, Malik
Hui, Kenrie P. Y.
Kam, Tonia T.
Chan, Michael C. W.
Bui, Christine H. T.
Wong, Peter C. H.
Poon, Leo L. M.
Yeung, Hin-Wo
Chin, Alex W. H.
Nicholls, John M.
Author_xml – sequence: 1
  givenname: Tonia T.
  surname: Kam
  fullname: Kam, Tonia T.
– sequence: 2
  givenname: Christine H. T.
  surname: Bui
  fullname: Bui, Christine H. T.
– sequence: 3
  givenname: Hin-Wo
  surname: Yeung
  fullname: Yeung, Hin-Wo
– sequence: 4
  givenname: Peter C. H.
  surname: Wong
  fullname: Wong, Peter C. H.
– sequence: 5
  givenname: Alex W. H.
  surname: Chin
  fullname: Chin, Alex W. H.
– sequence: 6
  givenname: John M.
  surname: Nicholls
  fullname: Nicholls, John M.
– sequence: 7
  givenname: Malik
  surname: Peiris
  fullname: Peiris, Malik
– sequence: 8
  givenname: Kenrie P. Y.
  surname: Hui
  fullname: Hui, Kenrie P. Y.
– sequence: 9
  givenname: Leo L. M.
  surname: Poon
  fullname: Poon, Leo L. M.
– sequence: 10
  givenname: Michael C. W.
  surname: Chan
  fullname: Chan, Michael C. W.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40597362$$D View this record in MEDLINE/PubMed
BookMark eNptkttq3DAQhk1JaQ7tC_SiCHqTXDjVwbasqxJC2w2EFHqid2JWO95V8EpbSd5u8zh90sq7SchCMcZi5pvfM6P_uDhw3mFRvGb0nLG2eRcZV21dUj6-rWhK9qw4YrISZcX5z4Mn58PiOMZbSgVvpHpRHFa0VlI0_Kj4-8MG6IlZQACTMNg7SNY74juSFkgCQow-JHApkimm34iOGHDWIbGu6wd0d0Am4oYTcDOyGJbgyCofcWkNOeWUqjMyYTdsm4a1zemJyvTahiFizCIPcrjJwbUnKTeywNwTblb9-N-XxfMO-oiv7r8nxfePH75dTsrrz5-uLi-uS1NzkUqokbGqbZACq6Sh1bgcVs3QMOC8lh2bYkMlzZSkVCKXleJMNpVpOiVELU6Kq53uzMOtXgW7hPBHe7B6G_BhriEka3rUYFrBZ5WsMddD10wlTlWrhFK1bKE1Wev9Tms1TJc4M-jyWP2e6H7G2YWe-7VmPPekqMgKp_cKwf8aMCa9tNFgn1eCfohacN6IWol2RN_u0Dnk3vK1-HGHI64v2qoRVFWyzdT5f6j8bO8qO6uzOb5XcLZXkJmEmzSHIUZ99fXLPvvm6byPgz4YLQN8B5jgYwzYPSKM6tHNeudmnd2st27WTPwD2v_kOg
Cites_doi 10.4172/1747-0862.1000028
10.1128/JVI.00887-14
10.1093/infdis/jiab002
10.1371/journal.ppat.1008409
10.1016/0042-6822(79)90430-6
10.1128/JVI.00702-11
10.1128/jvi.01763-01716
10.1128/JVI.00637-17
10.1128/JVI.01140-10
10.1111/j.1750-2659.2012.00379.x
10.1017/S0950268814001617
10.1099/vir.0.037739-0
10.1016/j.vetmic.2020.108970
10.1371/journal.pone.0162163
10.7554/eLife.83470
10.1016/j.vetmic.2009.01.019
10.1007/s11262-015-1272-z
10.1073/pnas.96.16.9363
10.1016/S0140-6736(02)11772-7
10.1136/bmjresp-2023-001638
10.1016/j.virusres.2014.08.020
10.1186/s12985-015-0343-z
10.3201/eid2510.190196
10.1128/JVI.72.9.7367-7373.1998
10.1016/j.vetmic.2010.12.011
10.1186/s13567-017-0453-2
10.1055/s-0036-1584801
10.3201/eid1405.071471
10.1016/j.meegid.2012.11.018
10.1093/molbev/msv044
10.3201/eid2312.170246
ContentType Journal Article
Copyright 2025. The Author(s).
COPYRIGHT 2025 BioMed Central Ltd.
The Author(s) 2025 2025
Copyright_xml – notice: 2025. The Author(s).
– notice: COPYRIGHT 2025 BioMed Central Ltd.
– notice: The Author(s) 2025 2025
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISR
7X8
5PM
DOA
DOI 10.1186/s12985-025-02836-1
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Science
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic




MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1743-422X
EndPage 10
ExternalDocumentID oai_doaj_org_article_ac832d475e764af6b7eb989399578a8c
PMC12217903
A846309478
40597362
10_1186_s12985_025_02836_1
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Hong Kong, China
GeographicLocations_xml – name: Hong Kong, China
GrantInformation_xml – fundername: NIH HHS
  grantid: 75N93021C00016
– fundername: Theme-Based Research Scheme, University Grants Committee
  grantid: T11-712/19-N
– fundername: NIAID NIH HHS
  grantid: 75N93021C00016
– fundername: InnoHK
  grantid: C2i
– fundername: Health and Medical Research Fund
  grantid: 18171262
GroupedDBID ---
0R~
123
29Q
2WC
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAHBH
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACMJI
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IGS
IHR
INH
INR
ISR
ITC
KQ8
LGEZI
LOTEE
M1P
M~E
NADUK
NXXTH
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
UKHRP
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c523t-a5e11486e0a147c04298514dec1a2257f1be6070e117007e274921764c6f93353
IEDL.DBID DOA
ISSN 1743-422X
IngestDate Wed Aug 27 01:31:12 EDT 2025
Thu Aug 21 18:33:36 EDT 2025
Fri Jul 11 16:55:12 EDT 2025
Wed Jul 16 16:53:06 EDT 2025
Tue Jul 15 03:51:54 EDT 2025
Sat Jul 12 02:48:24 EDT 2025
Sat Aug 02 01:40:57 EDT 2025
Thu Jul 03 08:32:23 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Explants
Canine H3N2
Ex vivo
H9N2
Influenza
Pandemic H1N1
Reassortment
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c523t-a5e11486e0a147c04298514dec1a2257f1be6070e117007e274921764c6f93353
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/ac832d475e764af6b7eb989399578a8c
PMID 40597362
PQID 3226359383
PQPubID 23479
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_ac832d475e764af6b7eb989399578a8c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12217903
proquest_miscellaneous_3226359383
gale_infotracmisc_A846309478
gale_infotracacademiconefile_A846309478
gale_incontextgauss_ISR_A846309478
pubmed_primary_40597362
crossref_primary_10_1186_s12985_025_02836_1
PublicationCentury 2000
PublicationDate 2025-07-01
PublicationDateYYYYMMDD 2025-07-01
PublicationDate_xml – month: 07
  year: 2025
  text: 2025-07-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Virology journal
PublicationTitleAlternate Virol J
PublicationYear 2025
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References L Martinez-Sobrido (2836_CR21) 2020; 16
A Moreno (2836_CR16) 2011; 149
CKP Mok (2836_CR22) 2011; 85
IH Lee (2836_CR15) 2016; 52
C Wang (2836_CR24) 2016; 11
C Cheung (2836_CR27) 2002; 360
T Ito (2836_CR8) 1998; 72
H Sun (2836_CR29) 2017; 91
H Kim (2836_CR6) 2013; 7
W Na (2836_CR12) 2015; 12
C Lee (2836_CR5) 2009; 137
D Song (2836_CR13) 2012; 93
W Ma (2836_CR9) 2009; 3
JS Weese (2836_CR3) 2019; 25
D Zhao (2836_CR31) 2021; 253
K-S Lyoo (2836_CR7) 2015; 195
2836_CR17
KB Zeldovich (2836_CR23) 2015; 32
CP Octaviani (2836_CR18) 2010; 84
G Gonzalez (2836_CR11) 2014; 88
D Song (2836_CR1) 2008; 14
H Moon (2836_CR14) 2015; 143
M Chen (2836_CR30) 2023; 12
S Su (2836_CR4) 2013; 14
IE Voorhees (2836_CR2) 2017; 23
MD Lubeck (2836_CR28) 1979; 95
M Gu (2836_CR19) 2017; 48
CH Bui (2836_CR10) 2021; 224
2836_CR25
Z Luyan (2836_CR26) 2023; 10
2836_CR20
References_xml – volume: 3
  start-page: 158
  issue: 1
  year: 2009
  ident: 2836_CR9
  publication-title: J Mol Genetic Medicine: Int J Biomedical Res
  doi: 10.4172/1747-0862.1000028
– volume: 88
  start-page: 9208
  issue: 16
  year: 2014
  ident: 2836_CR11
  publication-title: J Virol
  doi: 10.1128/JVI.00887-14
– volume: 224
  start-page: 821
  issue: 5
  year: 2021
  ident: 2836_CR10
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jiab002
– volume: 16
  start-page: e1008409
  issue: 4
  year: 2020
  ident: 2836_CR21
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1008409
– volume: 95
  start-page: 269
  issue: 1
  year: 1979
  ident: 2836_CR28
  publication-title: Virology
  doi: 10.1016/0042-6822(79)90430-6
– volume: 85
  start-page: 9641
  issue: 18
  year: 2011
  ident: 2836_CR22
  publication-title: J Virol
  doi: 10.1128/JVI.00702-11
– ident: 2836_CR17
  doi: 10.1128/jvi.01763-01716
– volume: 91
  start-page: jvi10112800637
  issue: 21
  year: 2017
  ident: 2836_CR29
  publication-title: J Virol
  doi: 10.1128/JVI.00637-17
– volume: 84
  start-page: 10918
  issue: 20
  year: 2010
  ident: 2836_CR18
  publication-title: J Virol
  doi: 10.1128/JVI.01140-10
– volume: 7
  start-page: 265
  issue: 3
  year: 2013
  ident: 2836_CR6
  publication-title: Influenza Other Respir Viruses
  doi: 10.1111/j.1750-2659.2012.00379.x
– volume: 143
  start-page: 772
  issue: 4
  year: 2015
  ident: 2836_CR14
  publication-title: Epidemiol Infect
  doi: 10.1017/S0950268814001617
– volume: 93
  start-page: 551
  issue: 3
  year: 2012
  ident: 2836_CR13
  publication-title: J Gen Virol
  doi: 10.1099/vir.0.037739-0
– volume: 253
  start-page: 108970
  year: 2021
  ident: 2836_CR31
  publication-title: Vet Microbiol
  doi: 10.1016/j.vetmic.2020.108970
– volume: 11
  start-page: e0162163
  issue: 9
  year: 2016
  ident: 2836_CR24
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0162163
– volume: 12
  start-page: e83470
  year: 2023
  ident: 2836_CR30
  publication-title: Elife
  doi: 10.7554/eLife.83470
– volume: 137
  start-page: 359
  issue: 3–4
  year: 2009
  ident: 2836_CR5
  publication-title: Vet Microbiol
  doi: 10.1016/j.vetmic.2009.01.019
– volume: 52
  start-page: 142
  year: 2016
  ident: 2836_CR15
  publication-title: Virus Genes
  doi: 10.1007/s11262-015-1272-z
– ident: 2836_CR20
  doi: 10.1073/pnas.96.16.9363
– volume: 360
  start-page: 1831
  issue: 9348
  year: 2002
  ident: 2836_CR27
  publication-title: Lancet
  doi: 10.1016/S0140-6736(02)11772-7
– volume: 10
  start-page: e001638
  issue: 1
  year: 2023
  ident: 2836_CR26
  publication-title: BMJ Open Respiratory Res
  doi: 10.1136/bmjresp-2023-001638
– volume: 195
  start-page: 135
  year: 2015
  ident: 2836_CR7
  publication-title: Virus Res
  doi: 10.1016/j.virusres.2014.08.020
– volume: 12
  start-page: 1
  year: 2015
  ident: 2836_CR12
  publication-title: Virol J
  doi: 10.1186/s12985-015-0343-z
– volume: 25
  start-page: 1810
  issue: 10
  year: 2019
  ident: 2836_CR3
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid2510.190196
– volume: 72
  start-page: 7367
  issue: 9
  year: 1998
  ident: 2836_CR8
  publication-title: J Virol
  doi: 10.1128/JVI.72.9.7367-7373.1998
– volume: 149
  start-page: 472
  issue: 3
  year: 2011
  ident: 2836_CR16
  publication-title: Vet Microbiol
  doi: 10.1016/j.vetmic.2010.12.011
– volume: 48
  start-page: 1
  year: 2017
  ident: 2836_CR19
  publication-title: Vet Res
  doi: 10.1186/s13567-017-0453-2
– ident: 2836_CR25
  doi: 10.1055/s-0036-1584801
– volume: 14
  start-page: 741
  issue: 5
  year: 2008
  ident: 2836_CR1
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid1405.071471
– volume: 14
  start-page: 444
  year: 2013
  ident: 2836_CR4
  publication-title: Infect Genet Evol
  doi: 10.1016/j.meegid.2012.11.018
– volume: 32
  start-page: 1519
  issue: 6
  year: 2015
  ident: 2836_CR23
  publication-title: Mol Biol Evol
  doi: 10.1093/molbev/msv044
– volume: 23
  start-page: 1950
  issue: 12
  year: 2017
  ident: 2836_CR2
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid2312.170246
SSID ssj0032679
Score 2.4089413
Snippet In 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread internationally and...
Background In 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread...
Abstract Background In 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 218
SubjectTerms Animals
Canine H3N2
Coinfection - virology
Dog Diseases - virology
Dogs
Ex vivo
Genetic aspects
H9N2
Humans
Influenza
Influenza A Virus, H1N1 Subtype - genetics
Influenza A Virus, H1N1 Subtype - isolation & purification
Influenza A Virus, H1N1 Subtype - physiology
Influenza A Virus, H3N2 Subtype - genetics
Influenza A Virus, H3N2 Subtype - isolation & purification
Influenza A Virus, H3N2 Subtype - physiology
Influenza A Virus, H9N2 Subtype - genetics
Influenza A Virus, H9N2 Subtype - isolation & purification
Influenza A Virus, H9N2 Subtype - physiology
Influenza viruses
Influenza, Human - virology
Orthomyxoviridae Infections - veterinary
Orthomyxoviridae Infections - virology
Pandemic H1N1
Physiological aspects
Reassortant Viruses - genetics
Reassortant Viruses - isolation & purification
Reassortment
Trachea - virology
Virus research
Title Viral characterization of the reassortants between canine influenza H3N2 and human pandemic (2009) H1N1 and avian H9N2 viruses in canine ex vivo tracheal explants
URI https://www.ncbi.nlm.nih.gov/pubmed/40597362
https://www.proquest.com/docview/3226359383
https://pubmed.ncbi.nlm.nih.gov/PMC12217903
https://doaj.org/article/ac832d475e764af6b7eb989399578a8c
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdgCMQLggFbYFQGIQFC0eo68cdjhzaFSqvQxlDfLMdxINJIqqWtgD-Hv5S7fFSNeOCFhyiSffmw73z3u-R8R8jrKE9Zxiys79zbMAL1FyrBVJhznmumvYwtOornc5FcRbNFvNgp9YUxYW164Hbijq0DmcsiGXspIpuLVPpUg5HVGmTNKofaF2xe70y1OhgwidT9Fhkljmuwagp3IuOhuAjZwAw12fr_1sk7RmkYMLljgc4ekgcddKTT9pUfkVu-3Cd322KSP_fJvfPuN_lj8vtLAddTt03G3O61pFVOAe9RjEOvEXaXq5p2gVoUphiupUVbtOSXpQmfT6gtM9qU8aNL_Nr8vXD0Lf7peEcTNmdNt92AhNFEA_WmuFnXvoab9LfzP6BxU1EYj0NMCg3La3zuE3J1dvr5QxJ2xRhCB77qKrSxR9dJ-LFlkXRoxwCsRZl3zIJOkDlLvQD94bGUzVh68HY1uDsiciLXnMf8Kdkrq9IfEqpTrxzACOszcGZSphVgGJbF1rt4bLkOyPueN2bZ5twwja-ihGk5aYCTpuGkYQE5QfZtKTFfdtMAUmQ6KTL_kqKAvELmG8yIUWLIzVe7rmvz8fLCTAGhcXCCpQrIm44or3DabLeDAUaFSbQGlEcDSliybtD9spcxg10Y51b6al0bUK-AADVXPCAHrcxtBwbQWkvAGwFRA2kcjHzYUxbfmozhbDLBTGz82f-Yq-fk_qRZSRizfET2Vjdr_wKQ2SodkdtyIUfkznQ6u5zB-eR0_uli1CzNP-MmNwE
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Viral+characterization+of+the+reassortants+between+canine+influenza+H3N2+and+human+pandemic+H1N1+and+avian+H9N2+viruses+in+canine+ex+vivo+tracheal+explants&rft.jtitle=Virology+journal&rft.au=Kam%2C+Tonia+T&rft.au=Bui%2C+Christine+H.+T&rft.au=Yeung%2C+Hin-Wo&rft.au=Wong%2C+Peter+C.+H&rft.date=2025-07-01&rft.pub=BioMed+Central+Ltd&rft.issn=1743-422X&rft.eissn=1743-422X&rft.volume=22&rft.issue=1&rft_id=info:doi/10.1186%2Fs12985-025-02836-1&rft.externalDBID=ISR&rft.externalDocID=A846309478
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1743-422X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1743-422X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1743-422X&client=summon